ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "mental health"

  • Abstract Number: 0285 • ACR Convergence 2023

    Patient Reported Physical Function, Mental Health, and Treatment Patterns in Dermatomyositis

    Lisa Christopher-Stine1, Julie Paik1, Brendan M. Johnson2, Taryn Smith2, Jolie Feldman2 and Paul N. Mudd Jr.2, 1Johns Hopkins University, Baltimore, MD, 2Priovant Therapeutics, Durham, NC

    Background/Purpose: Dermatomyositis (DM) is a rare, debilitating, idiopathic inflammatory myopathy characterized by painful, itchy skin rash and proximal muscle weakness that can significantly impact daily…
  • Abstract Number: 1970 • ACR Convergence 2023

    Impaired Health-Related Quality of Life in Patients with Idiopathic Inflammatory Myopathies: A Cross-Sectional Analysis from the COVAD Dataset

    Akira Yoshida1, Yuan Li2, Vahed Maroufy2, Masataka Kuwana1, Naveen R3, Ashima Makol4, Parikshit Sen5, James Lilleker6, Vishwesh Agarwal7, Sinan Kardes8, Jessica Day9, Marcin Milchert10, Mrudula Joshi11, Tamer A Gheita12, Babur Salim13, Tsvetelina Velikova14, Abraham Edgar Gracia-Ramos15, Ioannis Parodis16, Elena Nikiphorou17, Ai Lyn Tan18, Arvind Nune19, Lorenzo Cavagna20, Miguel Angel Saavedra Salinas21, Samuel Shinjo22, Nelly Ziade23, Johannes Knitza24, Oliver Distler25, Hector Chinoy26, Vikas Agarwal3, Rohit Aggarwal27, Latika Gupta28 and COVAD Study Group29, 1Nippon Medical School Graduate School of Medicine, Tokyo, Japan, 2University of Texas Health Science Center at Houston, Houston, TX, 3Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India, 4Mayo Clinic, Rochester, MN, Rochester, MN, 5Maulana Azad Medical College, 2-Bahadurshah Zafar Marg, New Delhi, Delhi-110002, India., Dalhi, India, 6Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK; Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK. Orcid ID: 0000-0002-9230-4137., Manchester, United Kingdom, 7Mahatma Gandhi Missions Medical College, Lucknow, India, 8Istanbul University, Istanbul, Turkey, 9Walter and Eliza Hall Institute, Melbourne, Australia, 10Department of Internal Medicine, Rheumatology, Diabetology, Geriatrics and Clinical Immunology, Pomeranian Medical University in Szczecin, Szczecin, Poland, 11Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, India, 12Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt, 13Fauji foundation hospital Rawalpindi, Rawalpindi, Pakistan, 14Department of Clinical Immunology, Medical Faculty, University Hospital "Lozenetz", Sofia University St. Kliment Ohridski, Sofia, Bulgaria, 15Department of Internal Medicine, General Hospital, National Medical Center "La Raza", Instituto Mexicano del Seguro Social, Av. Jacaranda S/N, Col. La Raza, Del. Azcapotzalco, C.P. 02990, Mexico City, Mexico, 16Karolinska Institutet, Stockholm, Sweden, 17King's College London, London, United Kingdom, 18University of Leeds, Leeds, United Kingdom, 19Southport & Ormskirk NHS Foundation Trust, Liverpool, United Kingdom, 20Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, 21IMSS, Mexico City, Mexico, 22Faculdade de Medicina FMUSP, Universidade de Sao Paulo, São Paulo, Brazil, 23Saint-Joseph University, Beirut, Lebanon, 24Department of Internal Medicine 3 Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany, 25Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 26The University of Manchester, Sale, United Kingdom, 27University of Pittsburgh, Pittsburgh, PA, 28Royal Wolverhampton Trust, Wolverhampton/University of Manchester, United Kingdom, 29-, -

    Background/Purpose: The significance of Health-related quality of life (HRQoL) in patients with autoimmune diseases is well acknowledged. Unfortunately, there is dearth of data on the…
  • Abstract Number: 0329 • ACR Convergence 2023

    Factors Associated with Suicidal Ideation Among Patients with Inflammatory Rheumatic Musculoskeletal Disease: A Case-Control Study

    Eike von Schlichting1, Jan Dieris-Hirche2, Imke Redeker3, Xenofon Baraliakos4 and Uta Kiltz5, 1Ruhr-Universität Bochum and Rheumazentrum Ruhrgebiet, Herne, Germany, 2LWL-University Hospital, Department of Psychosomatic Medicine and Psychotherapy, Ruhr Universität Bochum, Bochum, Germany, 3Ruhr Universität Bochum, Bochum, Germany, 4Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 5Rheumazentrum Ruhrgebiet, Herne, Germany

    Background/Purpose: Mental health contributes to the morbidity of patients with inflammatory rheumatic musculoskeletal disease (iRMD). Despite extensive research conducted on the prevalence of depressive disorders,…
  • Abstract Number: 2056 • ACR Convergence 2023

    Pediatric Acute-onset Neuropsychiatric Syndrome: Markers of Inflammation/autoimmunity at Clinical Presentation and Eventual Development of Arthritis and Other Autoimmune Diseases

    Meiqian Ma1, Erin Masteron2 and Jennifer Frankovich1, 1Stanford University School of Medicine, Palo Alto, CA, 2University of Washington School of Public Health, Seattle, WA

    Background/Purpose: Certain psychiatric conditions are associated with systemic inflammatory processes. We aimed to evaluate whether a pediatric condition characterized by a sudden onset of severe…
  • Abstract Number: 0362 • ACR Convergence 2023

    Adverse Childhood Experiences Are Associated with Disease Outcomes in Youth with Juvenile Idiopathic Arthritis

    Danielle Bullock1, Ilir Agalliu2, Evin Rothschild2, Kaveh Ardalan3, Erica Lawson4, Natoshia Cunningham5, William Soulsby4, Nicole Reitz6, Laura Bouslaugh7, Anna Diggs8, Elizabeth Kessler9, Sara Kramer1, Bhupinder Nahal4, Cassandra Davis10, Ashley Kemp1, Riley O'Connor1, Tiffany Chinn4, Kathy Nguyen4, Paige Hill1 and Tamar Rubinstein11, 1University of Minnesota, Minneapolis, MN, 2Albert Einstein College of Medicine, Bronx, NY, 3Duke University School of Medicine, Durham, NC, 4University of California San Francisco, San Francisco, CA, 5Michigan State University, Grand Rapids, MI, 6CARRA, Allendale, MI, 7CARRA, Washington, DC, 8CARRA, Tipton, MO, 9Spectrum Health, Grand Rapids, MI, 10University of Utah, Salt Lake City, UT, 11Albert Einstein College of Medicine, Children's Hospital at Montefiore, White Plains, NY

    Background/Purpose: Adverse childhood events (ACEs) are common in children. ACEs are various stressors, including, but not limited to parental incarceration or food and housing insecurity.…
  • Abstract Number: 2057 • ACR Convergence 2023

    Medical Trauma and Its Association with Pain and Disability Risk in Children with Inflammatory Arthritis

    Leah Medrano1, Brenda Bursch1, Jennifer Weiss2, Alice Hoftman1, Joshua Li3, Nicholas Jackson3 and Deborah McCurdy1, 1David Geffen School of Medicine, UCLA, Los Angeles, CA, 2Hackensack Meridian School of Medicine, Hackensack, NJ, 3Department of Medicine Statistics Core, David Geffen School of Medicine, UCLA, Los Angeles, CA

    Background/Purpose: This study aims to determine the prevalence of medical trauma and its impacts on outcomes in a sample of children with inflammatory arthritis. We…
  • Abstract Number: 0549 • ACR Convergence 2023

    Development of Customized Digital Cognitive Assessment Battery: A Pilot Use Case in SLE Patients

    Priyanka Srivastava1 and Liza Rajasekhar2, 1International Institute of Information Technology, Hyderabad, India, 2Nizam's Institute of Medical Sciences, Madhapur, India

    Background/Purpose: Reported prevalence of cognitive dysfunction (CD) in SLE varies from 3%-88%1.Variability may be due to use of tools insensitive to population characteristics like literacy,…
  • Abstract Number: 2062 • ACR Convergence 2023

    A Mental Health Workshop for Pediatric Rheumatology Fellows

    Caitlan Pinotti1, Alison Manning2, Suzanne Edison3 and Rebecca Sadun1, 1Duke University, Durham, NC, 2Lifespan, East Providence, RI, 3Cure JM Foundation, Seattle, WA

    Background/Purpose: Many children with a rheumatic disease have concurrent mental and behavioral health challenges, but only ~40% of these symptoms are brought to medical attention.…
  • Abstract Number: 0994 • ACR Convergence 2023

    Narrative Medicine and Pediatric Rheumatology: Addressing Burnout and Bias

    Aviya Lanis, Natalie Rosenwasser and Esi Morgan, Seattle Children's Hospital, Seattle, WA

    Background/Purpose: Burnout, a syndrome of emotional exhaustion and depersonalization, adversely impacts healthcare and results in mood disturbances, poor patient and provider satisfaction and high turnover.…
  • Abstract Number: 2268 • ACR Convergence 2023

    Mental Illness and Outcomes of COVID-19 in Patients with Systemic Lupus Erythematosus: A Global Multicenter Cohort Study

    Hsin-Hua Chen, Taichung Veterans General Hospital, Taichung, Taiwan

    Background/Purpose: Poor COVID-19 outcomes in patients with systemic lupus erythematosus (SLE) has been found to be associated with glucocorticoid dose, male sex, older age, mycophenolate,…
  • Abstract Number: 006 • 2023 Pediatric Rheumatology Symposium

    Implementation of Automated Depression Screening in Patients with Lupus in a Tertiary Pediatric Rheumatology Clinic

    Lauren Harper1, Alana Goldstein-Leever1, James Gallup1, Vidya Sivaraman2, Stacy Ardoin1, Kyla Driest1, Evan Mulvhihill3 and Alysha Taxter4, 1Nationwide Children's Hospital, Columbus, OH, 2Nationwide Children's Hospital/ The Ohio State University, Columbus, OH, 3Nemours Children's Hospital, 4Nationwide Children's Hospital, Columbus, OH

    Background/Purpose: Patients with chronic rheumatic conditions, particularly lupus, have higher rates of depression, which significantly impacts their lives and can lead to poor medication compliance…
  • Abstract Number: 010 • 2023 Pediatric Rheumatology Symposium

    Remotely Delivered Psychological Intervention May Be Beneficial to Youth with Childhood-Onset Lupus: A Preliminary Investigation

    Natoshia Cunningham1, Michelle Adler2, Ashley Danguecan3, Mallet Reid2, Samantha Ely4, Mathew Reeves2, Lawrence Ng3, Paris Moaf3, Sarah Mossad3, Tala El Tal3, Luana Flores Pereira3, Deborah Levy3, Linda Hiraki3, Jennifer Stinson3, Sarah Ahola Kohut3, Khalid Abulaban5, Elizabeth Kessler5, Stacy Allen5, Tamar Rubinstein6, Evin Rothschild6, Natalie Rosenwasser7, Kabita Nanda7, Susan Canny7, Emily Smitherman8, Livie Huie8, James Birmingham9, Allison Thompson10, Janel Thompson10, Miranda Moyer10, Emily Nguyen10, Angela Chapson10 and Andrea Knight3, 1Michigan State University, Grand Rapids, MI, 2Michigan State University, East Lansing, 3The Hospital for Sick Children, Toronto, ON, Canada, 4Wayne State University, Michigan State University, Detroit, MI, 5Helen DeVos Children's Hospital, Grand Rapids, MI, 6Children's Hospital at Montefiore, New York, NY, 7Seattle Children's Hospital, Seattle, WA, 8University of Alabama at Birmingham, Birmingham, AL, 9Metro Health, Cleveland, 10Patient Co-Investigative Team

    Background/Purpose: Childhood-onset systemic lupus erythematosus (cSLE) is associated with fatigue, pain, and depressive symptoms that adversely impact health-related quality of life. The Treatment and Education…
  • Abstract Number: 022 • 2023 Pediatric Rheumatology Symposium

    Narrative Medicine and Pediatric Rheumatology: Addressing Burnout and Bias

    aviya lanis, Natalie Rosenwasser and Esi Morgan, Seattle Children's Hospital, Seattle, WA

    Background/Purpose: Burnout, a syndrome of emotional exhaustion and depersonalization, adversely impacts healthcare. This can result in mood disturbances, poor patient and provider satisfaction and high…
  • Abstract Number: 049 • 2023 Pediatric Rheumatology Symposium

    What Happens After Juvenile Myositis Patients Screen Positive for Mental Health Comorbidities? Update from a Multicenter Juvenile Myositis Mental Health Screening Pilot Study

    Kaveh Ardalan1, Rebecca Fillipo1, Christina ZIgler2, Audrey Ward1, Jeffrey Dvergsten3, Ann Reed1, Alison Manning1, Gary Maslow1, Brian Feldman4, Ashley Danguecan5, Sarah Mossad5, Luana Flores Pereira5, Susan Shenoi6, Stacey Haynes7, Joanna Patten7 and Andrea Knight5, 1Duke University School of Medicine, Durham, NC, 2Duke, Durham, NC, 3Duke University Hospital, Durham, NC, 4Hospital for Sick Children / University of Toronto, Toronto, ON, Canada, 5The Hospital for Sick Children, Toronto, ON, Canada, 6Seattle Children's Hospital, Seattle, WA, 7Seattle Childrens Hospital and Research Center / University of Washington, Seattle, WA

    Background/Purpose: Juvenile myositis (JM) patients report high rates of emotional distress but qualitative studies suggest challenges accessing high quality mental health care. We present survey…
  • Abstract Number: 058 • 2023 Pediatric Rheumatology Symposium

    High Levels of Psychological Distress, Depression, and Anxiety Symptoms in Children with Pediatric Rheumatologic Diseases

    Natalie Rosenwasser1, Tamar Rubinstein2, Andrea Knight3, Natoshia Cunningham4, Aimee Hersh5, Vincent Del Gaizo6 and Erin Treemarcki5, 1Seattle Children's Hospital, seattle, WA, 2Children's Hospital at Montefiore, New York, NY, 3The Hospital for Sick Children, Toronto, ON, Canada, 4Michigan State University, Grand Rapids, MI, 5University of Utah, Salt Lake City, UT, 6Childhood Arthritis & Rheumatology Research Alliance (CARRA), Whitehouse Station, NJ

    Background/Purpose: Mental health problems are common in children with pediatric rheumatologic diseases (PRDs) and are associated with worsened quality of life and poorer disease-related outcomes.…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology